CASI Pharmaceuticals CASIF Cash Flow Statement (2022-2025)

OTC CASIF
$0.13 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

CASI Pharmaceuticals Quarterly Cash Flow Statement

Periods 16 quarters
Latest Dec 2025

CASI Pharmaceuticals cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 16 quarters of results from Mar 2022 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income -8.15M-11.03M-8.15M-17.43M-5.63M-12.25M-4.64M-4.86M-9.43M-7.28M-8.44M-14.68M-11.20M-13.39M-10.91M-83.58M

CASI Pharmaceuticals Cash Flow Statement API

Pull CASI Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CASIF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY